Journal
CHEMISTRY & BIOLOGY
Volume 15, Issue 8, Pages 765-770Publisher
CELL PRESS
DOI: 10.1016/j.chembiol.2008.07.010
Keywords
-
Categories
Funding
- NIGMS [GM059334B, GM077596]
- U.S. National Institutes of Health Chemical Biology Interface Training [5T32 GM070421]
- National Science Foundation
- Institute for Genomic Biology Fellows Program
Ask authors/readers for more resources
The antibiotics fosmidomycin and FR900098 are members of a unique class of phosphonic acid natural products that inhibit the nonmevalonate pathway for isoprenoid biosynthesis. Both are potent antibacterial and antimalarial compounds, but despite their efficacy, little is known regarding their biosynthesis. Here we report the identification of the Streptomyces rubellomurinus genes required for the biosynthesis of FR900098. Expression of these genes in Streptomyces lividans results in production of FR900098, demonstrating their role in synthesis of the antibiotic. Analysis of the putative gene products suggests that FR900098 is synthesized by metabolic reactions analogous to portions of the tricarboxylic acid cycle. These data greatly expand our knowledge of phosphonate biosynthesis and enable efforts to overproduce this highly useful therapeutic agent.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available